TPCW
TD Private Client Wealth’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23
| Closed | -$5.6K | – | 1421 |
|
|
2025
Q1 | $5.6K | Buy |
23
+3
| +15% | +$731 | ﹤0.01% | 1070 |
|
|
2024
Q4 | $6.57K | Sell |
20
-51
| -72% | -$16.8K | ﹤0.01% | 1090 |
|
|
2024
Q3 | $23.8K | Sell |
71
-1
| -1% | -$335 | ﹤0.01% | 946 |
|
|
2024
Q2 | $19.7K | Sell |
72
-62
| -46% | -$16.9K | ﹤0.01% | 952 |
|
|
2024
Q1 | $46.3K | Sell |
134
-641
| -83% | -$222K | ﹤0.01% | 826 |
|
|
2023
Q4 | $250K | Sell |
775
-2,163
| -74% | -$698K | 0.01% | 524 |
|
|
2023
Q3 | $1.05M | Sell |
2,938
-48
| -2% | -$17.2K | 0.05% | 312 |
|
|
2023
Q2 | $1.13M | Buy |
2,986
+29
| +1% | +$11K | 0.05% | 310 |
|
|
2023
Q1 | $1.42M | Buy |
2,957
+282
| +11% | +$135K | 0.06% | 274 |
|
|
2022
Q4 | $1.12M | Buy |
2,675
+203
| +8% | +$85.4K | 0.05% | 300 |
|
|
2022
Q3 | $1.03M | Buy |
2,472
+202
| +9% | +$84.3K | 0.05% | 302 |
|
|
2022
Q2 | $1.12M | Buy |
2,270
+81
| +4% | +$40.1K | 0.05% | 298 |
|
|
2022
Q1 | $1.23M | Buy |
2,189
+322
| +17% | +$181K | 0.05% | 310 |
|
|
2021
Q4 | $1.41M | Sell |
1,867
-373
| -17% | -$282K | 0.06% | 289 |
|
|
2021
Q3 | $1.67M | Buy |
2,240
+85
| +4% | +$63.4K | 0.07% | 264 |
|
|
2021
Q2 | $1.39M | Buy |
2,155
+23
| +1% | +$14.8K | 0.06% | 289 |
|
|
2021
Q1 | $1.22M | Buy |
2,132
+447
| +27% | +$255K | 0.06% | 295 |
|
|
2020
Q4 | $982K | Sell |
1,685
-239
| -12% | -$139K | 0.05% | 303 |
|
|
2020
Q3 | $992K | Sell |
1,924
-26
| -1% | -$13.4K | 0.06% | 294 |
|
|
2020
Q2 | $880K | Buy |
1,950
+695
| +55% | +$314K | 0.05% | 298 |
|
|
2020
Q1 | $440K | Buy |
1,255
+272
| +28% | +$95.4K | 0.03% | 337 |
|
|
2019
Q4 | $364K | Buy |
+983
| New | +$364K | 0.02% | 390 |
|